How, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR positive NSCLC - 100004

Spotlight
Video

How, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR positive NSCLC

imedex has 1221 videos Subscribe Here

Loading........
Description: In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Vera Hirsh discusses how, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR-positive non-small cell lung cancer (NSCLC).

Earn CME Credit for a related activity: http://elc.imedex.com/ELC/S...

© 2017 Imedex, LLC.
Shared By : imedex
Posted on : 05/05/17
Added : 12 months ago